Pharmacokinetics, safety and tolerability of tramadol after multiple-dose
This clinical study focuses on tramadol, a medicine commonly prescribed to treat moderate to severe pain. Doctors already know how a single dose works, but this trial looks at what happens in the body when someone takes multiple doses over several days. Researchers will measure how tramadol is absorbed, broken down, and cleared by the body over time. They will also keep a close eye on safety and how well people tolerate the medicine. Because this is an early-stage Phase 1 trial, it involves healthy adults aged 18 and over rather than people currently in pain. Volunteers will attend a specialist research clinic, take the study medication, and have regular checks such as blood tests and heart monitoring. The findings will help doctors better understand the medicine, ensuring future patients receive the safest and most effective doses.
At a glance
What is this study about?
Tramadol is a well-known painkiller used across the NHS to help manage moderate to severe pain. When people suffer from ongoing pain, they rarely take just one tablet; they usually need repeated doses over several days or weeks. This study is designed to look closely at what happens inside the human body when tramadol is taken repeatedly over a specific schedule.
Scientists use the term 'pharmacokinetics' to describe the journey a medicine takes through the body. This includes how fast it enters the bloodstream, how it travels to different tissues, and how the liver and kidneys break it down and remove it. When someone takes several doses, a medicine can sometimes build up in the system. This trial tracks those levels carefully to see how the body balances and clears the drug over time.
Safety is another key part of this research. By giving the medicine to healthy volunteers under close medical supervision, doctors can track any side effects—such as nausea or drowsiness—without the confusion of other health conditions. This detailed information helps healthcare teams understand how to prescribe tramadol safely and choose the best dosage instructions for patients in the future.
Key takeaways
- The study looks at how the body handles repeated doses of tramadol over several days.
- It is a Phase 1 trial open to healthy adult volunteers aged 18 and older.
- Researchers will track medicine levels in the blood and monitor for common side effects.
- Taking part involves health checks, taking the study medicine, and regular blood tests at a clinic.
- Participation is entirely voluntary, and you can withdraw at any time.
Who may be eligible?
This study is open to healthy men and women aged 18 and older. Because the goal is to understand how the medicine behaves in a standard, healthy body, volunteers must not have any serious ongoing medical conditions.
You are unlikely to be able to take part if you have a history of liver, kidney, or heart problems, or if you have ever had issues with drug or alcohol dependence. People who take regular prescription medicines that could interact with tramadol will also be excluded.
Women who are pregnant, planning to become pregnant, or breastfeeding cannot take part. The study team will run health checks—such as blood tests, urine tests, and heart tracings—before anyone joins to make sure it is safe for them to participate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I consider myself to be in good general health.
- I do not have chronic kidney, liver, or heart problems.
- I am not currently taking regular prescription medicines.
- I am not pregnant or breastfeeding.
What does participation involve?
Taking part in this trial involves a screening visit followed by a short stay or repeated visits to a dedicated clinical research unit. During your first visit, doctors will review your medical history and run basic health checks to confirm you are safe to join.
If eligible, you will take tramadol on a strict schedule over several days. You will need to stay at the clinic or visit frequently so staff can take blood samples at set times. These samples show exactly how much medicine is in your blood throughout the day. The team will also check your blood pressure, heart rate, and temperature, and ask you how you are feeling.
After finishing the course of medication, you will have a final follow-up check to make sure the drug has left your body and that you feel completely back to normal. The entire process typically takes a few weeks from start to finish.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What is tramadol?
Tramadol is a strong painkiller used to treat moderate to severe pain. It works by changing the way your brain and nervous system respond to pain signals.
Why does the study need healthy volunteers instead of people in pain?
Testing the medicine in healthy people allows scientists to see how it acts on its own, without symptoms from other illnesses or other treatments interfering with the results.
Will I have to stay overnight in a clinic?
Phase 1 studies like this often require a short stay in a research unit so the team can take blood tests at regular times throughout the day and night.
What side effects might I experience?
The most common side effects of tramadol are mild and temporary. They include feeling sick, dizzy, lightheaded, tired, or having a dry mouth.
Can I leave the study early if I want to?
Yes. You have the right to withdraw from the trial at any time, for any reason, and your medical care will not be affected.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.